| Literature DB >> 34206755 |
Chi-Jung Chung1,2, Ning-Yi Hsia3, Chih-Da Wu4,5, Ting-Ju Lai1, Jein-Wen Chen6,7,8, Hui-Tsung Hsu1.
Abstract
Previous studies have indicated that women suffer from dry eye syndrome (DES) more significantly than men. Therefore, we specifically explore the associations between air pollutant levels and the risks of DES for women. The study obtained 27,605 participants from the 29 recruitment centers of the Taiwan Biobank, which was established in October 2012. A large scale cross-sectional study involving DES sufferers and age- and education-matched control groups without DES was designed. Based on the municipality of residence, the predicted concentration levels of various air pollutants, including PM2.5, sulfur dioxide (SO2), ozone (O3), and nitrogen dioxide (NO2) were estimated by using hybrid kriging/LUR model. Multiple logistic regressions were applied to estimate the prevalence ratios (PR) of DES and 95% confidence interval. Hormone supplementations, DBP, allergies, and arthritis were considered as important comorbidities for increased PR risk of DES. In addition, with each standard deviation (SD) increment of PM2.5 and temperature, women had significant increases in PRs of DES of 1.09- and 1.07-fold, respectively; conversely, each SD increment of relative humidity (RH) had a protective effect against the risk of DES. After considering hormone supplementation, arthritis, and allergy, the SD increment of NO2 and temperature were associated with the PRs of DES. In conclusion, significant associations of ambient NO2 concentration, RH and temperature with DES indicated the importance of increased environmental protection in the female population. Female exposure to high levels of NO2 when receiving hormone supplementation, or suffering with allergies or arthritis, had significantly increased risk of DES.Entities:
Keywords: NO2; PM2.5; air pollution; dry eye syndrome; land-use regression model
Year: 2021 PMID: 34206755 PMCID: PMC8296916 DOI: 10.3390/ijerph18136860
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Detailed flow chart of the recruitment procedure in this study.
Descriptive information of baseline characteristics of study participants.
| Variable | Case | Control | PR (95%CI) a |
|---|---|---|---|
| Age, Mean ± SD | 53.89 ± 9.95 | 53.55 ± 9.94 | |
| 30–40 | 148 (10.76) | 592 (10.76) | |
| 40–50 | 288 (20.93) | 1152 (20.93) | |
| 50–60 | 485 (35.25) | 1940 (35.25) | |
| 60–70 | 455 (33.07) | 1820 (33.07) | |
| Education | |||
| Elementary school or below | 138 (10.03) | 552 (10.03) | |
| High school | 612 (44.48) | 2448 (44.48) | |
| College or above | 626 (45.49) | 2504 (45.49) | |
| Marriage | |||
| Single | 142 (10.33) | 548 (9.97) | 1.09 (0.89–1.35) |
| Married | 965 (70.18) | 3970 (72.22) | 1 |
| Divorce | 268 (19.49) | 979 (17.81) | 1.11 (0.95–1.30) |
| Resident region | |||
| Northern | 654 (47.53) | 2822 (51.27) | 1.28 (0.93–1.76) |
| Central | 337 (24.49) | 1131 (20.55) | 1.67 (1.21–2.32) ** |
| Southern | 336 (24.42) | 1278 (23.22) | 1.46 (1.05–2.02) * |
| East | 49 (3.56) | 273 (4.96) | 1 |
| Job | |||
| No | 279 (56.14) | 1057 (51.54) | 1 |
| Yes | 218 (43.86) | 994 (48.46) | 0.85 (0.69–1.04) |
| Income | |||
| ≤3 thirty thousands | 265 (57.73) | 1116 (57.70) | 1 |
| 3–10 thirty thousands | 181 (39.43) | 755 (39.04) | 1.01 (0.82–1.26) |
| >10 thirty thousands | 13 (2.83) | 63 (3.26) | 0.88 (0.48–1.62) |
| Menopause | |||
| No | 484 (35.17) | 2066 (37.55) | 1 |
| Yes | 892 (64.83) | 3436 (62.45) | 1.13 (0.92–1.39) |
| Hormone supplementation | |||
| No | 374 (74.06) | 1689 (81.55) | 1 |
| Yes | 131 (25.94) | 382 (18.45) | 1.55 (1.22–1.95) ** |
| Cigarette smoking | |||
| No | 1351 (98.18) | 5390 (97.93) | 1 |
| Yes | 25 (1.82) | 114 (2.07) | 0.90 (0.58–1.40) |
| Alcohol drinking | |||
| No | 1358 (98.69) | 5412 (98.38) | 1 |
| Yes | 18 (1.31) | 89 (1.62) | 0.82 (0.49–1.36) |
| Sport habits | |||
| No | 688 (50.00) | 2893 (52.60) | 1 |
| Yes | 688 (50.00) | 2607 (47.40) | 1.10 (0.97–1.24) |
| Tea drinking | |||
| No | 368 (73.45) | 1538 (74.59) | 1 |
| Yes | 133 (26.55) | 524 (25.41) | 1.07 (0.86–1.34) |
| Coffee drinking | |||
| No | 320 (63.87) | 1280 (62.08) | 1 |
| Yes | 181 (36.13) | 782 (37.92) | 0.93 (0.76–1.14) |
PR: prevalence ratio; a Age and education were adjusted in the multiple logistic regression. * 0.01 < p < 0.05; ** p < 0.01.
Associations between clinical biochemistry index and individual histories of diseases as well as dry eye syndrome.
| Variable | Case | Control | PR (95%CI) a |
|---|---|---|---|
| BMI (kg/m2), per SD increment | 23.26 ± 3.34 | 23.66 ± 3.61 | 0.88 (0.83–0.94) ** |
| Waist to hip ratio, per SD increment | 0.85 ± 0.07 | 0.85 ± 0.07 | 0.93 (0.88–0.99) * |
| SBP (mmHg), per SD increment | 116.12 ± 17.26 | 118.03 ± 18.23 | 0.86 (0.80–0.92) ** |
| DBP (mmHg), per SD increment | 69.99 ± 9.99 | 71.03 ± 10.07 | 0.89 (0.84–0.95) ** |
| Fasting glucose (mg/dL), per SD increment | 94.80 ± 16.78 | 95.37 ± 19.80 | 0.96 (0.90–1.03) |
| HbA1c (%), per SD increment | 5.75 ± 0.66 | 5.77 ± 0.78 | 0.96 (0.90–1.02) |
| total Cholesterol (mg/dL), per SD increment | 200.88 ± 34.33 | 200.76 ± 35.85 | 1.00 (0.94–1.06) |
| TG (mg/dL), per SD increment | 104.43 ± 72.06 | 105.22 ± 72.44 | 0.98 (0.93–1.05) |
| HDL (mg/dL), per SD increment | 58.14 ± 13.37 | 57.73 ± 13.19 | 1.03 (0.97–1.09) |
| LDL (mg/dL), per SD increment | 122.66 ± 30.81 | 122.72 ± 31.90 | 0.99 (0.93–1.05) |
| TC/HDL ratio, per SD increment | 3.60 ± 0.91 | 3.63 ± 0.94 | 0.97 (0.91–1.03) |
| eGFR (ml/min per 1.73 m2), per SD increment | 102.60 ± 13.81 | 103.06 ± 13.35 | 0.98 (0.91–1.06) |
| FEV/FVC (%), per SD increment | 72.00 ± 18.39 | 71.70 ± 18.74 | 1.02 (0.94–1.10) |
| Individual histories of diseases | |||
| Allergy | |||
| No | 1184 (86.55) | 4985 (89.34) | 1 |
| Yes | 184 (13.45) | 584 (10.66) | 1.30 (1.09–1.55) ** |
| Osteoporosis | |||
| No | 1229 (89.64) | 5084 (92.72) | 1 |
| Yes | 142 (10.36) | 399 (7.28) | 1.46 (1.19–1.80) ** |
| Arthritis | |||
| No | 1203 (87.75) | 5123 (93.43) | 1 |
| Yes | 168 (12.25) | 360 (6.57) | 2.00 (1.64–2.43) ** |
| Gout | |||
| No | 1358 (99.05) | 5435 (99.12) | 1 |
| Yes | 13 (0.95) | 48 (0.88) | 1.06 (0.57–1.97) |
| Asthma | |||
| No | 1322 (96.64) | 5330 (97.05) | 1 |
| Yes | 46 (3.36) | 162 (2.95) | 1.15 (0.82–1.60) |
PR: prevalence ratio; Continuous data were presented with Mean ± SD. a Age and education were adjusted in the multiple logistic regression. * 0.01 < p < 0.05; ** p < 0.01.
The effects of various air pollutants on the risk of dry eye syndrome using logistic regression.
| Air Pollutants | Case | Control | PR (95%CI) a | PR (95%CI) b |
|---|---|---|---|---|
| PM2.5 (μg/m3), per SD increment | 31.16 ± 5.67 | 30.68 ± 5.78 | 1.09(1.02–1.15) ** | 1.04(0.94–1.15) |
| <28.13 | 446 (32.41) | 2017 (36.65) | Reference | Reference |
| ≥28.13 | 930 (67.59) | 3487 (63.35) | 1.21 (1.07–1.37) ** | 1.09 (0.88–1.36) |
| SO2 (ppb), per SD increment | 4.50 ± 1.53 | 4.44 ± 1.49 | 1.05(0.99–1.11) | 1.01(0.91–1.11) |
| <4.61 | 929 (67.51) | 3911 (71.06) | Reference | Reference |
| ≥4.61 | 447 (32.49) | 1593 (28.94) | 1.18 (1.04–1.35) ** | 1.20 (0.98–1.48) |
| NO2 (ppb), per SD increment | 19.41 ± 3.33 | 19.22 ± 3.42 | 1.06(0.99–1.12) | 1.05(0.93–1.19) |
| <17.02 | 390 (28.34) | 1828 (33.21) | Reference | Reference |
| ≥17.02 | 986 (71.66) | 3676 (66.79) | 1.25 (1.10–1.43) ** | 1.43 (1.15–1.78) ** |
| O3 (ppb), per SD increment | 26.58 ± 3.24 | 26.51 ± 3.29 | 1.02(0.96–1.09) | 1.01(0.89–1.15) |
| <28.89 | 954 (69.33) | 3968 (72.09) | Reference | Reference |
| ≥28.89 | 422 (30.67) | 1536 (27.91) | 1.15 (1.01–1.31) * | 0.98 (0.79–1.21) |
| RH (%), per SD increment | 77.93 ± 1.91 | 78.06 ± 1.89 | 0.93(0.88–0.99) * | 0.96(0.86–1.08) |
| <78.08 | 614 (44.62) | 2180 (39.61) | Reference | Reference |
| ≥78.08 | 762 (55.38) | 3324 (60.39) | 0.81 (0.72–0.92) ** | 0.90 (0.74–1.09) |
| Temp (°C), per SD increment | 22.70 ± 1.08 | 22.63 ± 1.08 | 1.07(1.01–1.13) * | 1.05(0.95–1.17) |
| <21.81 | 205 (14.90) | 1081 (19.64) | Reference | Reference |
| ≥21.81 | 1171 (85.10) | 4423 (80.36) | 1.40 (1.19–1.65) ** | 1.44 (1.09–1.89) ** |
PR: prevalence ratio; CS: case; CN: controls. a Age and education were adjusted in the multiple logistic regression. b Age, education, hormone supplement, arthritis, and allergy were adjusted in the multiple logistic regression. * 0.01 < p < 0.05; ** p < 0.01.
Interactions of various air pollutants and clinical diseases on risk of dry eye syndrome using multiple logistic regression.
| Pollutants | Allergy | PR (95%CI) a | Interaction | Arthritis | PR (95%CI) a | Interaction | Hormone Supplementation | PR (95%CI) a | Interaction |
|---|---|---|---|---|---|---|---|---|---|
| PM2.5 (μg/m3) | 0.7973 | 0.6271 | 0.4021 | ||||||
| <28.13 | No | Reference †,* | No | Reference †,** | No | Reference †,** | |||
| ≥28.13 | No | 1.11 (0.88–1.39) | No | 1.07 (0.85–1.35) | No | 1.15 (0.90–1.48) | |||
| <28.13 | Yes | 1.44 (0.86–2.43) | Yes | 1.54 (0.85–2.78) | Yes | 1.71 (1.14–2.57) ** | |||
| ≥28.13 | Yes | 1.47 (1.00–2.15) # | Yes | 1.96 (1.32–2.90) ** | Yes | 1.60 (1.15–2.22) ** | |||
| SO2 (ppb) | 0.2993 | 0.7514 | 0.6360 | ||||||
| <4.61 | No | Reference †,** | No | Reference † ** | No | Reference †,** | |||
| ≥4.61 | No | 1.15 (0.92–1.44) | No | 1.22 (0.98–1.51) # | No | 1.17 (0.93–1.48) | |||
| <4.61 | Yes | 1.19 (0.81–1.76) | Yes | 1.82 (1.22–2.71) ** | Yes | 1.43 (1.06–1.93) # | |||
| ≧4.61 | Yes | 1.88 (1.21–2.93) ** | Yes | 1.99 (1.22–3.26) ** | Yes | 1.88 (1.30–2.72) ** | |||
| NO2 (ppb) | 0.3186 | 0.0698 | 0.6130 | ||||||
| <17.02 | No | Reference †,** | No | Reference †,** | No | Reference †,** | |||
| ≥17.02 | No | 1.37 (1.09–1.73) ** | No | 1.33 (1.05–1.67) ** | No | 1.39 (1.08–1.78) # | |||
| <17.02 | Yes | 1.06 (0.60–1.90) | Yes | 1.07 (0.57–2.03) | Yes | 1.34 (0.86–2.10) | |||
| ≥17.02 | Yes | 2.05 (1.41–2.99) ** | Yes | 2.80 (1.88–4.16) ** | Yes | 2.13 (1.54–2.93) ** | |||
| O3 (ppb) | 0.3406 | 0.5012 | 0.6984 | ||||||
| <28.89 | No | Reference | No | Reference †,* | No | Reference †,** | |||
| ≥28.89 | No | 0.94 (0.75–1.18) | No | 0.95 (0.76–1.19) | No | 1.00 (0.79–1.27) | |||
| <28.89 | Yes | 1.22 (0.84–1.77) | Yes | 1.61 (1.08–2.41) * | Yes | 1.53 (1.15–2.04) ** | |||
| ≥28.89 | Yes | 1.54 (0.97–2.44) # | Yes | 1.91 (1.18–3.09) ** | Yes | 1.39 (0.95–2.04) # | |||
| RH (%) | 0.3648 | 0.7979 | 0.5390 | ||||||
| <78.08 | No | Reference | No | Reference †,# | No | Reference †,* | |||
| ≥78.08 | No | 0.93 (0.75–1.15) | No | 0.91 (0.73–1.12) | No | 0.87 (0.69–1.09) | |||
| <78.08 | Yes | 1.57 (1.03–2.38) * | Yes | 1.80 (1.17–2.78) ** | Yes | 1.37 (0.97–1.94) # | |||
| ≥78.08 | Yes | 1.11 (0.73–1.69) | Yes | 1.50 (0.95–2.38) # | Yes | 1.38 (1.00–1.90) # | |||
| Temperature (°C) | 0.3582 | 0.1673 | 0.8472 | ||||||
| <21.81 | No | Reference †,** | No | Reference †,** | No | Reference †,** | |||
| ≥21.81 | No | 1.37 (1.03–1.83) * | No | 1.34 (1.00–1.78) * | No | 1.46 (1.06–2.01) * | |||
| <21.81 | Yes | 0.93 (0.40–2.19) | Yes | 1.01 (0.43–2.38) | Yes | 1.57 (0.89–2.75) | |||
| ≥21.81 | Yes | 1.96 (1.32–2.90) ** | Yes | 2.58 (1.70–3.90) ** | Yes | 2.15 (1.48–3.12) ** |
PR: prevalence ratio; a Age, education, hormone supplement, arthritis and allergy were adjusted in the multiple logistic regression. b Interaction p values were calculated through multiplicative models. † trend p values with significance were shown. # 0.05 < p < 0.1; * 0.01 < p < 0.05; ** p < 0.01.
Stepwise logistic regression analysis.
| Variable | PR (95%CI) | |
|---|---|---|
| Hormone supplementation (Yes vs. No) | 1.47 (1.17–1.86) | 0.0012 |
| DBP (continuous) (mmHg) | 0.99 (0.98–1.00) | 0.0042 |
| Allergy (Yes vs. No) | 1.36 (1.01–1.82) | 0.0422 |
| Arthritis (Yes vs. No) | 1.76 (1.29–2.41) | 0.0004 |
| NO2 (ppb) ( >= 17.02 vs. < 17.02) | 1.43 (1.15–1.78) | 0.0015 |
PR: prevalence ratio. All relevant factors in Table 1, Table 2 and Table 3 were included in the stepwise logistic regression model.